nodes	percent_of_prediction	percent_of_DWPC	metapath
Etoposide—Topoisomerase Inhibitors—Mitoxantrone—sarcoma	0.227	0.49	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Epirubicin—sarcoma	0.122	0.265	CiPCiCtD
Etoposide—Topoisomerase Inhibitors—Doxorubicin—sarcoma	0.113	0.245	CiPCiCtD
Etoposide—uterine cancer—sarcoma	0.0619	0.22	CtDrD
Etoposide—muscle cancer—sarcoma	0.0491	0.174	CtDrD
Etoposide—testicular cancer—sarcoma	0.0461	0.164	CtDrD
Etoposide—germ cell cancer—sarcoma	0.0441	0.157	CtDrD
Etoposide—peripheral nervous system neoplasm—sarcoma	0.0407	0.145	CtDrD
Etoposide—lung cancer—sarcoma	0.0397	0.141	CtDrD
Etoposide—ABCC6—Dactinomycin—sarcoma	0.031	0.157	CbGbCtD
Etoposide—TOP2A—Mitoxantrone—sarcoma	0.0148	0.0746	CbGbCtD
Etoposide—ABCC10—Vincristine—sarcoma	0.0146	0.0737	CbGbCtD
Etoposide—TOP2A—Epirubicin—sarcoma	0.012	0.0604	CbGbCtD
Etoposide—ABCC6—Doxorubicin—sarcoma	0.0119	0.0603	CbGbCtD
Etoposide—ABCC3—Vincristine—sarcoma	0.00918	0.0464	CbGbCtD
Etoposide—ABCC1—Dactinomycin—sarcoma	0.00915	0.0462	CbGbCtD
Etoposide—ABCC10—Doxorubicin—sarcoma	0.00912	0.0461	CbGbCtD
Etoposide—ABCC1—Mitoxantrone—sarcoma	0.00819	0.0414	CbGbCtD
Etoposide—ABCC1—Epirubicin—sarcoma	0.00663	0.0335	CbGbCtD
Etoposide—TOP2A—Doxorubicin—sarcoma	0.00635	0.0321	CbGbCtD
Etoposide—ABCG2—Dactinomycin—sarcoma	0.00612	0.0309	CbGbCtD
Etoposide—ABCC3—Doxorubicin—sarcoma	0.00574	0.029	CbGbCtD
Etoposide—ABCC1—Vincristine—sarcoma	0.00564	0.0285	CbGbCtD
Etoposide—ABCG2—Mitoxantrone—sarcoma	0.00548	0.0277	CbGbCtD
Etoposide—CYP2E1—Dacarbazine—sarcoma	0.00504	0.0254	CbGbCtD
Etoposide—ABCC2—Vincristine—sarcoma	0.00417	0.0211	CbGbCtD
Etoposide—CYP2E1—Mitoxantrone—sarcoma	0.00391	0.0197	CbGbCtD
Etoposide—ABCG2—Vincristine—sarcoma	0.00377	0.0191	CbGbCtD
Etoposide—ABCC1—Doxorubicin—sarcoma	0.00352	0.0178	CbGbCtD
Etoposide—CYP1A2—Dacarbazine—sarcoma	0.00291	0.0147	CbGbCtD
Etoposide—CYP3A4—Thiotepa—sarcoma	0.00275	0.0139	CbGbCtD
Etoposide—ABCC2—Doxorubicin—sarcoma	0.00261	0.0132	CbGbCtD
Etoposide—ABCG2—Doxorubicin—sarcoma	0.00236	0.0119	CbGbCtD
Etoposide—ABCB1—Dactinomycin—sarcoma	0.00221	0.0112	CbGbCtD
Etoposide—CYP3A5—Vincristine—sarcoma	0.00209	0.0106	CbGbCtD
Etoposide—ABCB1—Mitoxantrone—sarcoma	0.00198	0.00998	CbGbCtD
Etoposide—ABCC6—dermis—sarcoma	0.00177	0.107	CbGeAlD
Etoposide—ABCB1—Vincristine—sarcoma	0.00136	0.00687	CbGbCtD
Etoposide—CYP3A4—Mitoxantrone—sarcoma	0.00118	0.00598	CbGbCtD
Etoposide—ABCB1—Doxorubicin—sarcoma	0.00085	0.00429	CbGbCtD
Etoposide—CYP3A4—Vincristine—sarcoma	0.000815	0.00412	CbGbCtD
Etoposide—CYP3A4—Doxorubicin—sarcoma	0.000509	0.00257	CbGbCtD
Etoposide—TOP2B—mammary gland—sarcoma	0.000394	0.0239	CbGeAlD
Etoposide—PTGS2—periosteum—sarcoma	0.000388	0.0235	CbGeAlD
Etoposide—GSTT1—hematopoietic system—sarcoma	0.000326	0.0198	CbGeAlD
Etoposide—PTGS2—leg—sarcoma	0.000309	0.0188	CbGeAlD
Etoposide—TOP2B—myometrium—sarcoma	0.00028	0.017	CbGeAlD
Etoposide—PTGS2—hindlimb—sarcoma	0.000276	0.0168	CbGeAlD
Etoposide—PTGS2—cartilage tissue—sarcoma	0.000272	0.0165	CbGeAlD
Etoposide—TOP2B—embryo—sarcoma	0.000269	0.0163	CbGeAlD
Etoposide—ABCC6—hematopoietic system—sarcoma	0.000265	0.0161	CbGeAlD
Etoposide—ABCC6—connective tissue—sarcoma	0.000255	0.0155	CbGeAlD
Etoposide—TOP2B—seminal vesicle—sarcoma	0.000253	0.0153	CbGeAlD
Etoposide—TOP2B—hematopoietic system—sarcoma	0.00024	0.0146	CbGeAlD
Etoposide—PTGS2—appendage—sarcoma	0.000237	0.0144	CbGeAlD
Etoposide—TOP2B—connective tissue—sarcoma	0.000231	0.014	CbGeAlD
Etoposide—GSTT1—lymphoid tissue—sarcoma	0.00023	0.0139	CbGeAlD
Etoposide—TOP2B—smooth muscle tissue—sarcoma	0.000212	0.0128	CbGeAlD
Etoposide—TOP2A—myometrium—sarcoma	0.000206	0.0125	CbGeAlD
Etoposide—TOP2A—Vindesine—Vincristine—sarcoma	0.000192	0.252	CbGdCrCtD
Etoposide—UGT1A1—hematopoietic system—sarcoma	0.000191	0.0116	CbGeAlD
Etoposide—TOP2B—cardiac atrium—sarcoma	0.000182	0.0111	CbGeAlD
Etoposide—TOP2B—uterus—sarcoma	0.000181	0.011	CbGeAlD
Etoposide—GSTP1—myometrium—sarcoma	0.000175	0.0106	CbGeAlD
Etoposide—ABCC10—myometrium—sarcoma	0.000175	0.0106	CbGeAlD
Etoposide—TOP2B—lymphoid tissue—sarcoma	0.000169	0.0103	CbGeAlD
Etoposide—GSTT1—liver—sarcoma	0.000169	0.0103	CbGeAlD
Etoposide—GSTP1—embryo—sarcoma	0.000169	0.0102	CbGeAlD
Etoposide—TOP2B—tendon—sarcoma	0.000159	0.00965	CbGeAlD
Etoposide—GSTP1—seminal vesicle—sarcoma	0.000158	0.00961	CbGeAlD
Etoposide—ABCC10—seminal vesicle—sarcoma	0.000158	0.00961	CbGeAlD
Etoposide—TOP2B—bone marrow—sarcoma	0.000154	0.00935	CbGeAlD
Etoposide—ABCC3—hematopoietic system—sarcoma	0.000151	0.00918	CbGeAlD
Etoposide—GSTP1—hematopoietic system—sarcoma	0.00015	0.00914	CbGeAlD
Etoposide—ABCC10—hematopoietic system—sarcoma	0.00015	0.00913	CbGeAlD
Etoposide—PTGS1—endothelium—sarcoma	0.00015	0.00908	CbGeAlD
Etoposide—CYP2C8—mammary gland—sarcoma	0.000149	0.00903	CbGeAlD
Etoposide—GSTP1—connective tissue—sarcoma	0.000145	0.0088	CbGeAlD
Etoposide—PTGS2—endothelium—sarcoma	0.000143	0.00868	CbGeAlD
Etoposide—ABCC6—liver—sarcoma	0.000137	0.00833	CbGeAlD
Etoposide—TOP2A—uterus—sarcoma	0.000133	0.0081	CbGeAlD
Etoposide—GSTP1—smooth muscle tissue—sarcoma	0.000133	0.00805	CbGeAlD
Etoposide—TOP2B—testis—sarcoma	0.000132	0.00799	CbGeAlD
Etoposide—GSTP1—skin of body—sarcoma	0.000131	0.00794	CbGeAlD
Etoposide—TOP2B—liver—sarcoma	0.000124	0.00756	CbGeAlD
Etoposide—ABCC1—myometrium—sarcoma	0.000124	0.00752	CbGeAlD
Etoposide—TOP2A—Vinorelbine—Vincristine—sarcoma	0.000121	0.159	CbGdCrCtD
Etoposide—TOP2A—tendon—sarcoma	0.000117	0.0071	CbGeAlD
Etoposide—GSTP1—cardiac atrium—sarcoma	0.000114	0.00694	CbGeAlD
Etoposide—ABCC10—cardiac atrium—sarcoma	0.000114	0.00693	CbGeAlD
Etoposide—GSTP1—uterus—sarcoma	0.000114	0.0069	CbGeAlD
Etoposide—ABCC10—uterus—sarcoma	0.000114	0.0069	CbGeAlD
Etoposide—TOP2A—bone marrow—sarcoma	0.000113	0.00688	CbGeAlD
Etoposide—ABCC1—seminal vesicle—sarcoma	0.000112	0.0068	CbGeAlD
Etoposide—GSTP1—lymphoid tissue—sarcoma	0.000106	0.00643	CbGeAlD
Etoposide—ABCC10—lymphoid tissue—sarcoma	0.000106	0.00643	CbGeAlD
Etoposide—ABCG2—myometrium—sarcoma	0.000103	0.00623	CbGeAlD
Etoposide—GSTP1—tendon—sarcoma	9.96e-05	0.00605	CbGeAlD
Etoposide—ABCC10—tendon—sarcoma	9.95e-05	0.00604	CbGeAlD
Etoposide—UGT1A1—liver—sarcoma	9.92e-05	0.00602	CbGeAlD
Etoposide—TOP2A—testis—sarcoma	9.68e-05	0.00588	CbGeAlD
Etoposide—GSTP1—bone marrow—sarcoma	9.65e-05	0.00586	CbGeAlD
Etoposide—ABCC10—bone marrow—sarcoma	9.64e-05	0.00585	CbGeAlD
Etoposide—TOP2B—lymph node—sarcoma	9.54e-05	0.00579	CbGeAlD
Etoposide—ABCG2—seminal vesicle—sarcoma	9.27e-05	0.00563	CbGeAlD
Etoposide—CYP2C8—hematopoietic system—sarcoma	9.06e-05	0.0055	CbGeAlD
Etoposide—CYP1A2—hematopoietic system—sarcoma	8.48e-05	0.00515	CbGeAlD
Etoposide—TOP2A—Vinblastine—Vincristine—sarcoma	8.32e-05	0.109	CbGdCrCtD
Etoposide—ABCC3—testis—sarcoma	8.28e-05	0.00503	CbGeAlD
Etoposide—GSTP1—testis—sarcoma	8.25e-05	0.00501	CbGeAlD
Etoposide—ABCC10—testis—sarcoma	8.24e-05	0.005	CbGeAlD
Etoposide—PTGS2—myometrium—sarcoma	8.18e-05	0.00496	CbGeAlD
Etoposide—CYP3A5—hematopoietic system—sarcoma	8.17e-05	0.00496	CbGeAlD
Etoposide—ABCC1—cardiac atrium—sarcoma	8.08e-05	0.0049	CbGeAlD
Etoposide—ABCC1—uterus—sarcoma	8.03e-05	0.00488	CbGeAlD
Etoposide—CYP2E1—seminal vesicle—sarcoma	8.02e-05	0.00487	CbGeAlD
Etoposide—ABCC2—tendon—sarcoma	7.99e-05	0.00485	CbGeAlD
Etoposide—PTGS2—embryo—sarcoma	7.86e-05	0.00478	CbGeAlD
Etoposide—ABCC3—liver—sarcoma	7.83e-05	0.00475	CbGeAlD
Etoposide—GSTP1—liver—sarcoma	7.8e-05	0.00473	CbGeAlD
Etoposide—ABCC10—liver—sarcoma	7.79e-05	0.00473	CbGeAlD
Etoposide—PTGS1—seminal vesicle—sarcoma	7.73e-05	0.00469	CbGeAlD
Etoposide—CYP2E1—hematopoietic system—sarcoma	7.62e-05	0.00463	CbGeAlD
Etoposide—PTGS2—seminal vesicle—sarcoma	7.39e-05	0.00449	CbGeAlD
Etoposide—PTGS1—hematopoietic system—sarcoma	7.34e-05	0.00446	CbGeAlD
Etoposide—PTGS1—connective tissue—sarcoma	7.07e-05	0.00429	CbGeAlD
Etoposide—ABCC1—tendon—sarcoma	7.04e-05	0.00427	CbGeAlD
Etoposide—PTGS2—hematopoietic system—sarcoma	7.02e-05	0.00426	CbGeAlD
Etoposide—TOP2A—lymph node—sarcoma	7.02e-05	0.00426	CbGeAlD
Etoposide—PTGS2—connective tissue—sarcoma	6.76e-05	0.0041	CbGeAlD
Etoposide—ABCG2—uterus—sarcoma	6.65e-05	0.00404	CbGeAlD
Etoposide—ABCC2—testis—sarcoma	6.62e-05	0.00402	CbGeAlD
Etoposide—PTGS1—smooth muscle tissue—sarcoma	6.47e-05	0.00393	CbGeAlD
Etoposide—PTGS1—skin of body—sarcoma	6.39e-05	0.00388	CbGeAlD
Etoposide—TOP2A—Idarubicin—Epirubicin—sarcoma	6.31e-05	0.083	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Epirubicin—sarcoma	6.31e-05	0.083	CbGdCrCtD
Etoposide—TOP2A—Doxorubicin—Epirubicin—sarcoma	6.31e-05	0.083	CbGdCrCtD
Etoposide—ABCC2—liver—sarcoma	6.26e-05	0.0038	CbGeAlD
Etoposide—PTGS2—smooth muscle tissue—sarcoma	6.18e-05	0.00375	CbGeAlD
Etoposide—CYP3A4—hematopoietic system—sarcoma	6.13e-05	0.00372	CbGeAlD
Etoposide—PTGS2—skin of body—sarcoma	6.1e-05	0.00371	CbGeAlD
Etoposide—ABCC3—lymph node—sarcoma	6e-05	0.00365	CbGeAlD
Etoposide—GSTP1—lymph node—sarcoma	5.98e-05	0.00363	CbGeAlD
Etoposide—ABCC10—lymph node—sarcoma	5.97e-05	0.00363	CbGeAlD
Etoposide—TOP2A—Epirubicin—Doxorubicin—sarcoma	5.83e-05	0.0768	CbGdCrCtD
Etoposide—TOP2A—Idarubicin—Doxorubicin—sarcoma	5.83e-05	0.0768	CbGdCrCtD
Etoposide—TOP2A—Daunorubicin—Doxorubicin—sarcoma	5.83e-05	0.0768	CbGdCrCtD
Etoposide—ABCC1—testis—sarcoma	5.83e-05	0.00354	CbGeAlD
Etoposide—ABCG2—bone marrow—sarcoma	5.65e-05	0.00343	CbGeAlD
Etoposide—PTGS1—cardiac atrium—sarcoma	5.58e-05	0.00339	CbGeAlD
Etoposide—PTGS1—uterus—sarcoma	5.55e-05	0.00337	CbGeAlD
Etoposide—ABCC1—liver—sarcoma	5.51e-05	0.00335	CbGeAlD
Etoposide—CYP2E1—lymphoid tissue—sarcoma	5.37e-05	0.00326	CbGeAlD
Etoposide—PTGS2—uterus—sarcoma	5.3e-05	0.00322	CbGeAlD
Etoposide—ABCB1—myometrium—sarcoma	5.06e-05	0.00307	CbGeAlD
Etoposide—CYP2E1—tendon—sarcoma	5.05e-05	0.00306	CbGeAlD
Etoposide—CYP2C8—testis—sarcoma	4.96e-05	0.00301	CbGeAlD
Etoposide—PTGS2—lymphoid tissue—sarcoma	4.94e-05	0.003	CbGeAlD
Etoposide—ABCB1—embryo—sarcoma	4.86e-05	0.00295	CbGeAlD
Etoposide—PTGS1—tendon—sarcoma	4.86e-05	0.00295	CbGeAlD
Etoposide—ABCG2—testis—sarcoma	4.83e-05	0.00293	CbGeAlD
Etoposide—ABCC2—lymph node—sarcoma	4.8e-05	0.00291	CbGeAlD
Etoposide—Hypertension—Mitoxantrone—sarcoma	4.76e-05	0.00118	CcSEcCtD
Etoposide—Sepsis—Doxorubicin—sarcoma	4.72e-05	0.00117	CcSEcCtD
Etoposide—Cardiac failure congestive—Epirubicin—sarcoma	4.71e-05	0.00116	CcSEcCtD
Etoposide—Chest pain—Mitoxantrone—sarcoma	4.69e-05	0.00116	CcSEcCtD
Etoposide—CYP2C8—liver—sarcoma	4.69e-05	0.00285	CbGeAlD
Etoposide—Paraesthesia—Thiotepa—sarcoma	4.68e-05	0.00116	CcSEcCtD
Etoposide—PTGS2—tendon—sarcoma	4.65e-05	0.00282	CbGeAlD
Etoposide—Discomfort—Mitoxantrone—sarcoma	4.64e-05	0.00115	CcSEcCtD
Etoposide—Somnolence—Thiotepa—sarcoma	4.63e-05	0.00114	CcSEcCtD
Etoposide—Anaphylactic shock—Vincristine—sarcoma	4.62e-05	0.00114	CcSEcCtD
Etoposide—Infection—Vincristine—sarcoma	4.59e-05	0.00113	CcSEcCtD
Etoposide—Phlebitis—Doxorubicin—sarcoma	4.58e-05	0.00113	CcSEcCtD
Etoposide—ABCB1—seminal vesicle—sarcoma	4.57e-05	0.00277	CbGeAlD
Etoposide—ABCG2—liver—sarcoma	4.56e-05	0.00277	CbGeAlD
Etoposide—Blood alkaline phosphatase increased—Doxorubicin—sarcoma	4.54e-05	0.00112	CcSEcCtD
Etoposide—Confusional state—Mitoxantrone—sarcoma	4.54e-05	0.00112	CcSEcCtD
Etoposide—Decreased appetite—Thiotepa—sarcoma	4.53e-05	0.00112	CcSEcCtD
Etoposide—Thrombocytopenia—Vincristine—sarcoma	4.52e-05	0.00112	CcSEcCtD
Etoposide—PTGS2—bone marrow—sarcoma	4.5e-05	0.00273	CbGeAlD
Etoposide—Anaphylactic shock—Mitoxantrone—sarcoma	4.5e-05	0.00111	CcSEcCtD
Etoposide—Gastrointestinal disorder—Thiotepa—sarcoma	4.5e-05	0.00111	CcSEcCtD
Etoposide—Decreased appetite—Dactinomycin—sarcoma	4.5e-05	0.00111	CcSEcCtD
Etoposide—Fatigue—Thiotepa—sarcoma	4.49e-05	0.00111	CcSEcCtD
Etoposide—Infection—Mitoxantrone—sarcoma	4.47e-05	0.0011	CcSEcCtD
Etoposide—Hyperhidrosis—Vincristine—sarcoma	4.47e-05	0.0011	CcSEcCtD
Etoposide—Fatigue—Dactinomycin—sarcoma	4.46e-05	0.0011	CcSEcCtD
Etoposide—Pain—Thiotepa—sarcoma	4.46e-05	0.0011	CcSEcCtD
Etoposide—Constipation—Thiotepa—sarcoma	4.46e-05	0.0011	CcSEcCtD
Etoposide—Pain—Dactinomycin—sarcoma	4.42e-05	0.00109	CcSEcCtD
Etoposide—Anaphylactoid reaction—Epirubicin—sarcoma	4.41e-05	0.00109	CcSEcCtD
Etoposide—Thrombocytopenia—Mitoxantrone—sarcoma	4.41e-05	0.00109	CcSEcCtD
Etoposide—Anorexia—Vincristine—sarcoma	4.4e-05	0.00109	CcSEcCtD
Etoposide—Tachycardia—Mitoxantrone—sarcoma	4.39e-05	0.00108	CcSEcCtD
Etoposide—CYP1A2—liver—sarcoma	4.39e-05	0.00267	CbGeAlD
Etoposide—Cardiac failure—Epirubicin—sarcoma	4.37e-05	0.00108	CcSEcCtD
Etoposide—Skin disorder—Mitoxantrone—sarcoma	4.37e-05	0.00108	CcSEcCtD
Etoposide—Cardiac failure congestive—Doxorubicin—sarcoma	4.36e-05	0.00108	CcSEcCtD
Etoposide—Hyperhidrosis—Mitoxantrone—sarcoma	4.35e-05	0.00107	CcSEcCtD
Etoposide—ABCB1—hematopoietic system—sarcoma	4.34e-05	0.00264	CbGeAlD
Etoposide—Hypotension—Vincristine—sarcoma	4.32e-05	0.00107	CcSEcCtD
Etoposide—Feeling abnormal—Thiotepa—sarcoma	4.29e-05	0.00106	CcSEcCtD
Etoposide—Anorexia—Mitoxantrone—sarcoma	4.29e-05	0.00106	CcSEcCtD
Etoposide—Feeling abnormal—Dactinomycin—sarcoma	4.26e-05	0.00105	CcSEcCtD
Etoposide—Gastrointestinal pain—Thiotepa—sarcoma	4.26e-05	0.00105	CcSEcCtD
Etoposide—CYP3A5—liver—sarcoma	4.24e-05	0.00257	CbGeAlD
Etoposide—Gastrointestinal pain—Dactinomycin—sarcoma	4.23e-05	0.00104	CcSEcCtD
Etoposide—ABCC1—lymph node—sarcoma	4.23e-05	0.00257	CbGeAlD
Etoposide—Hypotension—Mitoxantrone—sarcoma	4.2e-05	0.00104	CcSEcCtD
Etoposide—CYP2E1—testis—sarcoma	4.18e-05	0.00254	CbGeAlD
Etoposide—Paraesthesia—Vincristine—sarcoma	4.15e-05	0.00102	CcSEcCtD
Etoposide—Urticaria—Thiotepa—sarcoma	4.14e-05	0.00102	CcSEcCtD
Etoposide—Abdominal pain—Thiotepa—sarcoma	4.12e-05	0.00102	CcSEcCtD
Etoposide—Body temperature increased—Thiotepa—sarcoma	4.12e-05	0.00102	CcSEcCtD
Etoposide—Body temperature increased—Dactinomycin—sarcoma	4.09e-05	0.00101	CcSEcCtD
Etoposide—Abdominal pain—Dactinomycin—sarcoma	4.09e-05	0.00101	CcSEcCtD
Etoposide—Anaphylactoid reaction—Doxorubicin—sarcoma	4.08e-05	0.00101	CcSEcCtD
Etoposide—Cardiac arrest—Epirubicin—sarcoma	4.06e-05	0.001	CcSEcCtD
Etoposide—Cardiac failure—Doxorubicin—sarcoma	4.05e-05	0.001	CcSEcCtD
Etoposide—Paraesthesia—Mitoxantrone—sarcoma	4.04e-05	0.000998	CcSEcCtD
Etoposide—PTGS1—testis—sarcoma	4.02e-05	0.00244	CbGeAlD
Etoposide—Decreased appetite—Vincristine—sarcoma	4.02e-05	0.000992	CcSEcCtD
Etoposide—Dyspnoea—Mitoxantrone—sarcoma	4.01e-05	0.000991	CcSEcCtD
Etoposide—Somnolence—Mitoxantrone—sarcoma	4e-05	0.000988	CcSEcCtD
Etoposide—Gastrointestinal disorder—Vincristine—sarcoma	3.99e-05	0.000985	CcSEcCtD
Etoposide—Fatigue—Vincristine—sarcoma	3.98e-05	0.000984	CcSEcCtD
Etoposide—Pain—Vincristine—sarcoma	3.95e-05	0.000976	CcSEcCtD
Etoposide—Constipation—Vincristine—sarcoma	3.95e-05	0.000976	CcSEcCtD
Etoposide—CYP2E1—liver—sarcoma	3.95e-05	0.0024	CbGeAlD
Etoposide—Decreased appetite—Mitoxantrone—sarcoma	3.91e-05	0.000966	CcSEcCtD
Etoposide—Fatigue—Mitoxantrone—sarcoma	3.88e-05	0.000958	CcSEcCtD
Etoposide—Constipation—Mitoxantrone—sarcoma	3.85e-05	0.00095	CcSEcCtD
Etoposide—Pain—Mitoxantrone—sarcoma	3.85e-05	0.00095	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Epirubicin—sarcoma	3.84e-05	0.000949	CcSEcCtD
Etoposide—Hypersensitivity—Thiotepa—sarcoma	3.84e-05	0.000948	CcSEcCtD
Etoposide—Hypersensitivity—Dactinomycin—sarcoma	3.81e-05	0.000941	CcSEcCtD
Etoposide—Gastrointestinal pain—Vincristine—sarcoma	3.78e-05	0.000933	CcSEcCtD
Etoposide—Alanine aminotransferase increased—Epirubicin—sarcoma	3.77e-05	0.00093	CcSEcCtD
Etoposide—Cardiac arrest—Doxorubicin—sarcoma	3.76e-05	0.000928	CcSEcCtD
Etoposide—Asthenia—Thiotepa—sarcoma	3.74e-05	0.000923	CcSEcCtD
Etoposide—Asthenia—Dactinomycin—sarcoma	3.71e-05	0.000916	CcSEcCtD
Etoposide—Feeling abnormal—Mitoxantrone—sarcoma	3.71e-05	0.000916	CcSEcCtD
Etoposide—Dysphagia—Epirubicin—sarcoma	3.69e-05	0.000911	CcSEcCtD
Etoposide—Pruritus—Thiotepa—sarcoma	3.69e-05	0.000911	CcSEcCtD
Etoposide—Gastrointestinal pain—Mitoxantrone—sarcoma	3.68e-05	0.000909	CcSEcCtD
Etoposide—Abdominal pain—Vincristine—sarcoma	3.65e-05	0.000902	CcSEcCtD
Etoposide—Body temperature increased—Vincristine—sarcoma	3.65e-05	0.000902	CcSEcCtD
Etoposide—PTGS2—liver—sarcoma	3.64e-05	0.00221	CbGeAlD
Etoposide—Urticaria—Mitoxantrone—sarcoma	3.57e-05	0.000883	CcSEcCtD
Etoposide—Diarrhoea—Thiotepa—sarcoma	3.57e-05	0.000881	CcSEcCtD
Etoposide—Abdominal pain—Mitoxantrone—sarcoma	3.56e-05	0.000879	CcSEcCtD
Etoposide—Body temperature increased—Mitoxantrone—sarcoma	3.56e-05	0.000879	CcSEcCtD
Etoposide—Toxic epidermal necrolysis—Doxorubicin—sarcoma	3.56e-05	0.000878	CcSEcCtD
Etoposide—Diarrhoea—Dactinomycin—sarcoma	3.54e-05	0.000874	CcSEcCtD
Etoposide—Pancytopenia—Epirubicin—sarcoma	3.5e-05	0.000865	CcSEcCtD
Etoposide—ABCG2—lymph node—sarcoma	3.5e-05	0.00212	CbGeAlD
Etoposide—Alanine aminotransferase increased—Doxorubicin—sarcoma	3.48e-05	0.00086	CcSEcCtD
Etoposide—Neutropenia—Epirubicin—sarcoma	3.45e-05	0.000852	CcSEcCtD
Etoposide—Dizziness—Thiotepa—sarcoma	3.45e-05	0.000851	CcSEcCtD
Etoposide—Dysphagia—Doxorubicin—sarcoma	3.41e-05	0.000843	CcSEcCtD
Etoposide—Hypersensitivity—Vincristine—sarcoma	3.4e-05	0.000841	CcSEcCtD
Etoposide—TOP2A—Gastric Cancer Network 1—C21orf33—sarcoma	3.4e-05	0.143	CbGpPWpGaD
Etoposide—Hypersensitivity—Mitoxantrone—sarcoma	3.32e-05	0.000819	CcSEcCtD
Etoposide—Asthenia—Vincristine—sarcoma	3.32e-05	0.000819	CcSEcCtD
Etoposide—Vomiting—Thiotepa—sarcoma	3.31e-05	0.000818	CcSEcCtD
Etoposide—Pneumonia—Epirubicin—sarcoma	3.31e-05	0.000817	CcSEcCtD
Etoposide—Infestation NOS—Epirubicin—sarcoma	3.29e-05	0.000812	CcSEcCtD
Etoposide—Infestation—Epirubicin—sarcoma	3.29e-05	0.000812	CcSEcCtD
Etoposide—Vomiting—Dactinomycin—sarcoma	3.29e-05	0.000812	CcSEcCtD
Etoposide—Rash—Thiotepa—sarcoma	3.29e-05	0.000811	CcSEcCtD
Etoposide—Dermatitis—Thiotepa—sarcoma	3.28e-05	0.000811	CcSEcCtD
Etoposide—ABCB1—uterus—sarcoma	3.28e-05	0.00199	CbGeAlD
Etoposide—Headache—Thiotepa—sarcoma	3.26e-05	0.000806	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Epirubicin—sarcoma	3.26e-05	0.000806	CcSEcCtD
Etoposide—Rash—Dactinomycin—sarcoma	3.26e-05	0.000805	CcSEcCtD
Etoposide—Pancytopenia—Doxorubicin—sarcoma	3.24e-05	0.000801	CcSEcCtD
Etoposide—Renal failure—Epirubicin—sarcoma	3.23e-05	0.000799	CcSEcCtD
Etoposide—Asthenia—Mitoxantrone—sarcoma	3.23e-05	0.000797	CcSEcCtD
Etoposide—Neuropathy peripheral—Epirubicin—sarcoma	3.22e-05	0.000796	CcSEcCtD
Etoposide—Jaundice—Epirubicin—sarcoma	3.21e-05	0.000792	CcSEcCtD
Etoposide—Stomatitis—Epirubicin—sarcoma	3.21e-05	0.000792	CcSEcCtD
Etoposide—Neutropenia—Doxorubicin—sarcoma	3.19e-05	0.000788	CcSEcCtD
Etoposide—CYP3A4—liver—sarcoma	3.18e-05	0.00193	CbGeAlD
Etoposide—Diarrhoea—Vincristine—sarcoma	3.16e-05	0.000781	CcSEcCtD
Etoposide—Hepatobiliary disease—Epirubicin—sarcoma	3.11e-05	0.000768	CcSEcCtD
Etoposide—Nausea—Thiotepa—sarcoma	3.1e-05	0.000764	CcSEcCtD
Etoposide—Diarrhoea—Mitoxantrone—sarcoma	3.08e-05	0.00076	CcSEcCtD
Etoposide—Nausea—Dactinomycin—sarcoma	3.07e-05	0.000759	CcSEcCtD
Etoposide—Agranulocytosis—Epirubicin—sarcoma	3.07e-05	0.000758	CcSEcCtD
Etoposide—Pneumonia—Doxorubicin—sarcoma	3.06e-05	0.000756	CcSEcCtD
Etoposide—ABCB1—lymphoid tissue—sarcoma	3.06e-05	0.00186	CbGeAlD
Etoposide—Dizziness—Vincristine—sarcoma	3.06e-05	0.000755	CcSEcCtD
Etoposide—Infestation—Doxorubicin—sarcoma	3.04e-05	0.000752	CcSEcCtD
Etoposide—Infestation NOS—Doxorubicin—sarcoma	3.04e-05	0.000752	CcSEcCtD
Etoposide—Stevens-Johnson syndrome—Doxorubicin—sarcoma	3.02e-05	0.000745	CcSEcCtD
Etoposide—Renal failure—Doxorubicin—sarcoma	2.99e-05	0.000739	CcSEcCtD
Etoposide—Neuropathy peripheral—Doxorubicin—sarcoma	2.98e-05	0.000737	CcSEcCtD
Etoposide—Jaundice—Doxorubicin—sarcoma	2.97e-05	0.000733	CcSEcCtD
Etoposide—Stomatitis—Doxorubicin—sarcoma	2.97e-05	0.000733	CcSEcCtD
Etoposide—Hypoaesthesia—Epirubicin—sarcoma	2.94e-05	0.000726	CcSEcCtD
Etoposide—Vomiting—Vincristine—sarcoma	2.94e-05	0.000726	CcSEcCtD
Etoposide—PTGS1—lymph node—sarcoma	2.92e-05	0.00177	CbGeAlD
Etoposide—Urinary tract disorder—Epirubicin—sarcoma	2.92e-05	0.00072	CcSEcCtD
Etoposide—Rash—Vincristine—sarcoma	2.91e-05	0.00072	CcSEcCtD
Etoposide—Dermatitis—Vincristine—sarcoma	2.91e-05	0.000719	CcSEcCtD
Etoposide—Urethral disorder—Epirubicin—sarcoma	2.89e-05	0.000715	CcSEcCtD
Etoposide—Headache—Vincristine—sarcoma	2.89e-05	0.000715	CcSEcCtD
Etoposide—Hepatobiliary disease—Doxorubicin—sarcoma	2.88e-05	0.000711	CcSEcCtD
Etoposide—Vomiting—Mitoxantrone—sarcoma	2.86e-05	0.000707	CcSEcCtD
Etoposide—Agranulocytosis—Doxorubicin—sarcoma	2.84e-05	0.000702	CcSEcCtD
Etoposide—Rash—Mitoxantrone—sarcoma	2.84e-05	0.000701	CcSEcCtD
Etoposide—Dermatitis—Mitoxantrone—sarcoma	2.83e-05	0.0007	CcSEcCtD
Etoposide—Headache—Mitoxantrone—sarcoma	2.82e-05	0.000696	CcSEcCtD
Etoposide—Erythema multiforme—Epirubicin—sarcoma	2.79e-05	0.00069	CcSEcCtD
Etoposide—PTGS2—lymph node—sarcoma	2.79e-05	0.00169	CbGeAlD
Etoposide—ABCB1—bone marrow—sarcoma	2.78e-05	0.00169	CbGeAlD
Etoposide—Eye disorder—Epirubicin—sarcoma	2.76e-05	0.000682	CcSEcCtD
Etoposide—Nausea—Vincristine—sarcoma	2.74e-05	0.000678	CcSEcCtD
Etoposide—Cardiac disorder—Epirubicin—sarcoma	2.74e-05	0.000677	CcSEcCtD
Etoposide—Flushing—Epirubicin—sarcoma	2.74e-05	0.000677	CcSEcCtD
Etoposide—Hypoaesthesia—Doxorubicin—sarcoma	2.72e-05	0.000671	CcSEcCtD
Etoposide—Urinary tract disorder—Doxorubicin—sarcoma	2.7e-05	0.000666	CcSEcCtD
Etoposide—Angiopathy—Epirubicin—sarcoma	2.68e-05	0.000662	CcSEcCtD
Etoposide—Urethral disorder—Doxorubicin—sarcoma	2.68e-05	0.000662	CcSEcCtD
Etoposide—Nausea—Mitoxantrone—sarcoma	2.67e-05	0.00066	CcSEcCtD
Etoposide—Immune system disorder—Epirubicin—sarcoma	2.67e-05	0.000659	CcSEcCtD
Etoposide—Mediastinal disorder—Epirubicin—sarcoma	2.66e-05	0.000657	CcSEcCtD
Etoposide—Chills—Epirubicin—sarcoma	2.65e-05	0.000654	CcSEcCtD
Etoposide—Alopecia—Epirubicin—sarcoma	2.61e-05	0.000645	CcSEcCtD
Etoposide—Erythema multiforme—Doxorubicin—sarcoma	2.58e-05	0.000638	CcSEcCtD
Etoposide—Eye disorder—Doxorubicin—sarcoma	2.55e-05	0.000631	CcSEcCtD
Etoposide—Flushing—Doxorubicin—sarcoma	2.54e-05	0.000626	CcSEcCtD
Etoposide—Cardiac disorder—Doxorubicin—sarcoma	2.54e-05	0.000626	CcSEcCtD
Etoposide—Dysgeusia—Epirubicin—sarcoma	2.52e-05	0.000622	CcSEcCtD
Etoposide—Back pain—Epirubicin—sarcoma	2.49e-05	0.000614	CcSEcCtD
Etoposide—Angiopathy—Doxorubicin—sarcoma	2.48e-05	0.000612	CcSEcCtD
Etoposide—Muscle spasms—Epirubicin—sarcoma	2.47e-05	0.00061	CcSEcCtD
Etoposide—Immune system disorder—Doxorubicin—sarcoma	2.47e-05	0.00061	CcSEcCtD
Etoposide—Mediastinal disorder—Doxorubicin—sarcoma	2.46e-05	0.000608	CcSEcCtD
Etoposide—Chills—Doxorubicin—sarcoma	2.45e-05	0.000606	CcSEcCtD
Etoposide—Alopecia—Doxorubicin—sarcoma	2.41e-05	0.000596	CcSEcCtD
Etoposide—Ill-defined disorder—Epirubicin—sarcoma	2.39e-05	0.000589	CcSEcCtD
Etoposide—ABCB1—testis—sarcoma	2.38e-05	0.00144	CbGeAlD
Etoposide—Anaemia—Epirubicin—sarcoma	2.38e-05	0.000587	CcSEcCtD
Etoposide—Dysgeusia—Doxorubicin—sarcoma	2.33e-05	0.000575	CcSEcCtD
Etoposide—Malaise—Epirubicin—sarcoma	2.32e-05	0.000573	CcSEcCtD
Etoposide—Vertigo—Epirubicin—sarcoma	2.31e-05	0.00057	CcSEcCtD
Etoposide—Leukopenia—Epirubicin—sarcoma	2.3e-05	0.000568	CcSEcCtD
Etoposide—Back pain—Doxorubicin—sarcoma	2.3e-05	0.000568	CcSEcCtD
Etoposide—Muscle spasms—Doxorubicin—sarcoma	2.29e-05	0.000565	CcSEcCtD
Etoposide—Loss of consciousness—Epirubicin—sarcoma	2.26e-05	0.000558	CcSEcCtD
Etoposide—ABCB1—liver—sarcoma	2.25e-05	0.00137	CbGeAlD
Etoposide—Cough—Epirubicin—sarcoma	2.24e-05	0.000554	CcSEcCtD
Etoposide—Convulsion—Epirubicin—sarcoma	2.23e-05	0.00055	CcSEcCtD
Etoposide—Hypertension—Epirubicin—sarcoma	2.22e-05	0.000548	CcSEcCtD
Etoposide—Ill-defined disorder—Doxorubicin—sarcoma	2.21e-05	0.000545	CcSEcCtD
Etoposide—Anaemia—Doxorubicin—sarcoma	2.2e-05	0.000543	CcSEcCtD
Etoposide—Chest pain—Epirubicin—sarcoma	2.19e-05	0.000541	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	2.17e-05	0.000537	CcSEcCtD
Etoposide—Discomfort—Epirubicin—sarcoma	2.16e-05	0.000534	CcSEcCtD
Etoposide—Malaise—Doxorubicin—sarcoma	2.15e-05	0.00053	CcSEcCtD
Etoposide—Vertigo—Doxorubicin—sarcoma	2.14e-05	0.000528	CcSEcCtD
Etoposide—Leukopenia—Doxorubicin—sarcoma	2.13e-05	0.000526	CcSEcCtD
Etoposide—Confusional state—Epirubicin—sarcoma	2.12e-05	0.000522	CcSEcCtD
Etoposide—Anaphylactic shock—Epirubicin—sarcoma	2.1e-05	0.000518	CcSEcCtD
Etoposide—Loss of consciousness—Doxorubicin—sarcoma	2.09e-05	0.000516	CcSEcCtD
Etoposide—Infection—Epirubicin—sarcoma	2.08e-05	0.000515	CcSEcCtD
Etoposide—Cough—Doxorubicin—sarcoma	2.08e-05	0.000513	CcSEcCtD
Etoposide—Convulsion—Doxorubicin—sarcoma	2.06e-05	0.000509	CcSEcCtD
Etoposide—Thrombocytopenia—Epirubicin—sarcoma	2.05e-05	0.000507	CcSEcCtD
Etoposide—Hypertension—Doxorubicin—sarcoma	2.05e-05	0.000507	CcSEcCtD
Etoposide—Tachycardia—Epirubicin—sarcoma	2.05e-05	0.000506	CcSEcCtD
Etoposide—Skin disorder—Epirubicin—sarcoma	2.04e-05	0.000503	CcSEcCtD
Etoposide—Hyperhidrosis—Epirubicin—sarcoma	2.03e-05	0.000501	CcSEcCtD
Etoposide—Chest pain—Doxorubicin—sarcoma	2.03e-05	0.0005	CcSEcCtD
Etoposide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	2.01e-05	0.000497	CcSEcCtD
Etoposide—Discomfort—Doxorubicin—sarcoma	2e-05	0.000494	CcSEcCtD
Etoposide—Anorexia—Epirubicin—sarcoma	2e-05	0.000494	CcSEcCtD
Etoposide—Hypotension—Epirubicin—sarcoma	1.96e-05	0.000484	CcSEcCtD
Etoposide—Confusional state—Doxorubicin—sarcoma	1.96e-05	0.000483	CcSEcCtD
Etoposide—Anaphylactic shock—Doxorubicin—sarcoma	1.94e-05	0.000479	CcSEcCtD
Etoposide—Infection—Doxorubicin—sarcoma	1.93e-05	0.000476	CcSEcCtD
Etoposide—Thrombocytopenia—Doxorubicin—sarcoma	1.9e-05	0.000469	CcSEcCtD
Etoposide—Tachycardia—Doxorubicin—sarcoma	1.89e-05	0.000468	CcSEcCtD
Etoposide—Skin disorder—Doxorubicin—sarcoma	1.89e-05	0.000466	CcSEcCtD
Etoposide—Paraesthesia—Epirubicin—sarcoma	1.88e-05	0.000465	CcSEcCtD
Etoposide—Hyperhidrosis—Doxorubicin—sarcoma	1.88e-05	0.000464	CcSEcCtD
Etoposide—Dyspnoea—Epirubicin—sarcoma	1.87e-05	0.000462	CcSEcCtD
Etoposide—Somnolence—Epirubicin—sarcoma	1.87e-05	0.000461	CcSEcCtD
Etoposide—Anorexia—Doxorubicin—sarcoma	1.85e-05	0.000457	CcSEcCtD
Etoposide—Decreased appetite—Epirubicin—sarcoma	1.82e-05	0.00045	CcSEcCtD
Etoposide—Hypotension—Doxorubicin—sarcoma	1.81e-05	0.000448	CcSEcCtD
Etoposide—Gastrointestinal disorder—Epirubicin—sarcoma	1.81e-05	0.000447	CcSEcCtD
Etoposide—Fatigue—Epirubicin—sarcoma	1.81e-05	0.000447	CcSEcCtD
Etoposide—Constipation—Epirubicin—sarcoma	1.79e-05	0.000443	CcSEcCtD
Etoposide—Pain—Epirubicin—sarcoma	1.79e-05	0.000443	CcSEcCtD
Etoposide—Paraesthesia—Doxorubicin—sarcoma	1.74e-05	0.000431	CcSEcCtD
Etoposide—Dyspnoea—Doxorubicin—sarcoma	1.73e-05	0.000427	CcSEcCtD
Etoposide—Feeling abnormal—Epirubicin—sarcoma	1.73e-05	0.000427	CcSEcCtD
Etoposide—Somnolence—Doxorubicin—sarcoma	1.73e-05	0.000426	CcSEcCtD
Etoposide—ABCB1—lymph node—sarcoma	1.72e-05	0.00105	CbGeAlD
Etoposide—Gastrointestinal pain—Epirubicin—sarcoma	1.72e-05	0.000424	CcSEcCtD
Etoposide—Decreased appetite—Doxorubicin—sarcoma	1.69e-05	0.000417	CcSEcCtD
Etoposide—Gastrointestinal disorder—Doxorubicin—sarcoma	1.68e-05	0.000414	CcSEcCtD
Etoposide—Fatigue—Doxorubicin—sarcoma	1.67e-05	0.000413	CcSEcCtD
Etoposide—Urticaria—Epirubicin—sarcoma	1.67e-05	0.000412	CcSEcCtD
Etoposide—Constipation—Doxorubicin—sarcoma	1.66e-05	0.00041	CcSEcCtD
Etoposide—Pain—Doxorubicin—sarcoma	1.66e-05	0.00041	CcSEcCtD
Etoposide—Abdominal pain—Epirubicin—sarcoma	1.66e-05	0.00041	CcSEcCtD
Etoposide—Body temperature increased—Epirubicin—sarcoma	1.66e-05	0.00041	CcSEcCtD
Etoposide—Feeling abnormal—Doxorubicin—sarcoma	1.6e-05	0.000395	CcSEcCtD
Etoposide—Gastrointestinal pain—Doxorubicin—sarcoma	1.59e-05	0.000392	CcSEcCtD
Etoposide—Hypersensitivity—Epirubicin—sarcoma	1.55e-05	0.000382	CcSEcCtD
Etoposide—Urticaria—Doxorubicin—sarcoma	1.54e-05	0.000381	CcSEcCtD
Etoposide—Abdominal pain—Doxorubicin—sarcoma	1.53e-05	0.000379	CcSEcCtD
Etoposide—Body temperature increased—Doxorubicin—sarcoma	1.53e-05	0.000379	CcSEcCtD
Etoposide—Asthenia—Epirubicin—sarcoma	1.51e-05	0.000372	CcSEcCtD
Etoposide—Pruritus—Epirubicin—sarcoma	1.48e-05	0.000367	CcSEcCtD
Etoposide—Diarrhoea—Epirubicin—sarcoma	1.44e-05	0.000355	CcSEcCtD
Etoposide—Hypersensitivity—Doxorubicin—sarcoma	1.43e-05	0.000353	CcSEcCtD
Etoposide—Asthenia—Doxorubicin—sarcoma	1.39e-05	0.000344	CcSEcCtD
Etoposide—Dizziness—Epirubicin—sarcoma	1.39e-05	0.000343	CcSEcCtD
Etoposide—Pruritus—Doxorubicin—sarcoma	1.37e-05	0.000339	CcSEcCtD
Etoposide—Vomiting—Epirubicin—sarcoma	1.33e-05	0.000329	CcSEcCtD
Etoposide—Diarrhoea—Doxorubicin—sarcoma	1.33e-05	0.000328	CcSEcCtD
Etoposide—Rash—Epirubicin—sarcoma	1.32e-05	0.000327	CcSEcCtD
Etoposide—Dermatitis—Epirubicin—sarcoma	1.32e-05	0.000326	CcSEcCtD
Etoposide—Headache—Epirubicin—sarcoma	1.31e-05	0.000325	CcSEcCtD
Etoposide—Dizziness—Doxorubicin—sarcoma	1.28e-05	0.000317	CcSEcCtD
Etoposide—Nausea—Epirubicin—sarcoma	1.25e-05	0.000308	CcSEcCtD
Etoposide—Vomiting—Doxorubicin—sarcoma	1.23e-05	0.000305	CcSEcCtD
Etoposide—Rash—Doxorubicin—sarcoma	1.22e-05	0.000302	CcSEcCtD
Etoposide—Dermatitis—Doxorubicin—sarcoma	1.22e-05	0.000302	CcSEcCtD
Etoposide—Headache—Doxorubicin—sarcoma	1.22e-05	0.0003	CcSEcCtD
Etoposide—Nausea—Doxorubicin—sarcoma	1.15e-05	0.000285	CcSEcCtD
Etoposide—ABCC1—S1P1 pathway—PLCG1—sarcoma	7.04e-06	0.0297	CbGpPWpGaD
Etoposide—ABCC3—Fluoropyrimidine Activity—SMUG1—sarcoma	5.32e-06	0.0224	CbGpPWpGaD
Etoposide—ABCC1—S1P1 pathway—PDGFRB—sarcoma	4.99e-06	0.021	CbGpPWpGaD
Etoposide—PTGS2—S1P1 pathway—PLCG1—sarcoma	4.73e-06	0.0199	CbGpPWpGaD
Etoposide—ABCC3—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	4.2e-06	0.0177	CbGpPWpGaD
Etoposide—CYP2E1—Folate-Alcohol and Cancer Pathway—CREB1—sarcoma	4.16e-06	0.0175	CbGpPWpGaD
Etoposide—ABCC1—S1P1 pathway—KDR—sarcoma	4.13e-06	0.0174	CbGpPWpGaD
Etoposide—ABCG2—HIF-2-alpha transcription factor network—FLT1—sarcoma	3.96e-06	0.0167	CbGpPWpGaD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—MITF—sarcoma	3.81e-06	0.016	CbGpPWpGaD
Etoposide—ABCG2—Fluoropyrimidine Activity—SMUG1—sarcoma	3.67e-06	0.0154	CbGpPWpGaD
Etoposide—UGT1A1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.42e-06	0.0144	CbGpPWpGaD
Etoposide—PTGS2—S1P1 pathway—PDGFRB—sarcoma	3.35e-06	0.0141	CbGpPWpGaD
Etoposide—ABCC2—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	3.33e-06	0.014	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—NPM1—sarcoma	3.11e-06	0.0131	CbGpPWpGaD
Etoposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	2.96e-06	0.0124	CbGpPWpGaD
Etoposide—PTGS2—S1P1 pathway—KDR—sarcoma	2.77e-06	0.0117	CbGpPWpGaD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—ATF1—sarcoma	2.75e-06	0.0116	CbGpPWpGaD
Etoposide—TOP2A—Gastric Cancer Network 2—CTNNB1—sarcoma	2.53e-06	0.0106	CbGpPWpGaD
Etoposide—ABCG2—HIF-2-alpha transcription factor network—KDR—sarcoma	2.28e-06	0.00962	CbGpPWpGaD
Etoposide—ABCC1—S1P1 pathway—VEGFA—sarcoma	2.28e-06	0.00959	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—CXCR4—sarcoma	2.2e-06	0.00926	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	2.11e-06	0.00889	CbGpPWpGaD
Etoposide—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—MDM2—sarcoma	2.1e-06	0.00884	CbGpPWpGaD
Etoposide—CYP3A5—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	2.08e-06	0.00875	CbGpPWpGaD
Etoposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	2.06e-06	0.00867	CbGpPWpGaD
Etoposide—TOP2A—Gastric Cancer Network 2—MYC—sarcoma	2.05e-06	0.00862	CbGpPWpGaD
Etoposide—PTGS1—Selenium Micronutrient Network—HBA1—sarcoma	2.05e-06	0.00862	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CD34—sarcoma	2.03e-06	0.00857	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—MYOD1—sarcoma	2.03e-06	0.00857	CbGpPWpGaD
Etoposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	2.03e-06	0.00853	CbGpPWpGaD
Etoposide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—JUN—sarcoma	2.01e-06	0.00846	CbGpPWpGaD
Etoposide—TOP2A—Gastric Cancer Network 2—EGFR—sarcoma	2e-06	0.00843	CbGpPWpGaD
Etoposide—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—sarcoma	1.75e-06	0.00739	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—NPM1—sarcoma	1.68e-06	0.00709	CbGpPWpGaD
Etoposide—TOP2A—Gastric Cancer Network 2—TP53—sarcoma	1.68e-06	0.00708	CbGpPWpGaD
Etoposide—PTGS2—Selenium Micronutrient Network—HBA1—sarcoma	1.62e-06	0.00684	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—FLT1—sarcoma	1.6e-06	0.00673	CbGpPWpGaD
Etoposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	1.57e-06	0.00662	CbGpPWpGaD
Etoposide—ABCB1—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	1.57e-06	0.0066	CbGpPWpGaD
Etoposide—PTGS2—S1P1 pathway—VEGFA—sarcoma	1.53e-06	0.00644	CbGpPWpGaD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—CREB1—sarcoma	1.49e-06	0.00629	CbGpPWpGaD
Etoposide—ABCC3—Fluoropyrimidine Activity—TP53—sarcoma	1.41e-06	0.00595	CbGpPWpGaD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	1.37e-06	0.00577	CbGpPWpGaD
Etoposide—CYP1A2—Melatonin metabolism and effects—FOXO1—sarcoma	1.35e-06	0.0057	CbGpPWpGaD
Etoposide—CYP1A2—Estrogen Receptor Pathway—JUN—sarcoma	1.34e-06	0.00565	CbGpPWpGaD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	1.33e-06	0.00561	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—MDM2—sarcoma	1.28e-06	0.0054	CbGpPWpGaD
Etoposide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—sarcoma	1.28e-06	0.0054	CbGpPWpGaD
Etoposide—ABCG2—HIF-2-alpha transcription factor network—VEGFA—sarcoma	1.26e-06	0.0053	CbGpPWpGaD
Etoposide—PTGS2—Calcium signaling in the CD4+ TCR pathway—JUN—sarcoma	1.25e-06	0.00525	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—STAG1—sarcoma	1.23e-06	0.00519	CbGpPWpGaD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	1.2e-06	0.00504	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—CXCR4—sarcoma	1.19e-06	0.00501	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—CREB1—sarcoma	1.18e-06	0.00496	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	1.12e-06	0.00472	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—sarcoma	1.12e-06	0.00471	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRB—sarcoma	1.11e-06	0.00469	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—STAG1—sarcoma	1.1e-06	0.00464	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—PDGFRA—sarcoma	1.1e-06	0.00461	CbGpPWpGaD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—JUN—sarcoma	1.07e-06	0.00452	CbGpPWpGaD
Etoposide—UGT1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	1.05e-06	0.00441	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	9.8e-07	0.00413	CbGpPWpGaD
Etoposide—ABCG2—Fluoropyrimidine Activity—TP53—sarcoma	9.74e-07	0.0041	CbGpPWpGaD
Etoposide—CYP3A4—Constitutive Androstane Receptor Pathway—FOXO1—sarcoma	9.65e-07	0.00407	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—NPM1—sarcoma	9.46e-07	0.00398	CbGpPWpGaD
Etoposide—CYP2E1—Tryptophan metabolism—MDM2—sarcoma	9.34e-07	0.00393	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—ENO2—sarcoma	9.19e-07	0.00387	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—HBA1—sarcoma	9.13e-07	0.00385	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—MYC—sarcoma	8.96e-07	0.00378	CbGpPWpGaD
Etoposide—ABCG2—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	8.64e-07	0.00364	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—sarcoma	8.49e-07	0.00358	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—JUN—sarcoma	8.47e-07	0.00357	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—sarcoma	8.29e-07	0.00349	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	8.27e-07	0.00348	CbGpPWpGaD
Etoposide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—JUN—sarcoma	8.07e-07	0.0034	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—CREB1—sarcoma	7.94e-07	0.00334	CbGpPWpGaD
Etoposide—TOP2A—Mitotic G1-G1/S phases—CCND1—sarcoma	7.86e-07	0.00331	CbGpPWpGaD
Etoposide—GSTT1—Metabolism—PLCG1—sarcoma	7.79e-07	0.00328	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—KIT—sarcoma	7.78e-07	0.00328	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—SRC—sarcoma	7.74e-07	0.00326	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—MDM2—sarcoma	7.55e-07	0.00318	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	7.53e-07	0.00317	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—PDGFRA—sarcoma	7.47e-07	0.00315	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	7.44e-07	0.00313	CbGpPWpGaD
Etoposide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—sarcoma	7.4e-07	0.00312	CbGpPWpGaD
Etoposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—sarcoma	7.36e-07	0.0031	CbGpPWpGaD
Etoposide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—sarcoma	7.08e-07	0.00298	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—WT1—sarcoma	6.95e-07	0.00293	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—MYC—sarcoma	6.93e-07	0.00292	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	6.84e-07	0.00288	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	6.78e-07	0.00286	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—JUN—sarcoma	6.56e-07	0.00276	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	6.41e-07	0.0027	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—CREB1—sarcoma	6.37e-07	0.00268	CbGpPWpGaD
Etoposide—TOP2A—Mitotic G1-G1/S phases—MYC—sarcoma	6.31e-07	0.00266	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	5.96e-07	0.00251	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	5.94e-07	0.0025	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	5.9e-07	0.00248	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—VEGFA—sarcoma	5.73e-07	0.00241	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—JUN—sarcoma	5.71e-07	0.0024	CbGpPWpGaD
Etoposide—CYP1A2—Tryptophan metabolism—MDM2—sarcoma	5.61e-07	0.00237	CbGpPWpGaD
Etoposide—PTGS2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	5.44e-07	0.00229	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—CCND1—sarcoma	5.34e-07	0.00225	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	5.33e-07	0.00225	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	5.2e-07	0.00219	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	5.19e-07	0.00219	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—ENO2—sarcoma	5.03e-07	0.00212	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—sarcoma	5.02e-07	0.00211	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—HBA1—sarcoma	5e-07	0.00211	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—JUN—sarcoma	4.88e-07	0.00206	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	4.78e-07	0.00201	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	4.67e-07	0.00197	CbGpPWpGaD
Etoposide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—sarcoma	4.67e-07	0.00197	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—NRAS—sarcoma	4.6e-07	0.00194	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—JUN—sarcoma	4.58e-07	0.00193	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	4.42e-07	0.00186	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—SRC—sarcoma	4.38e-07	0.00184	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—SRC—sarcoma	4.38e-07	0.00184	CbGpPWpGaD
Etoposide—CYP3A4—Tryptophan metabolism—MDM2—sarcoma	4.33e-07	0.00183	CbGpPWpGaD
Etoposide—GSTP1—Cellular responses to stress—TP53—sarcoma	4.33e-07	0.00182	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—MYC—sarcoma	4.28e-07	0.0018	CbGpPWpGaD
Etoposide—GSTP1—Metabolism—PLCG1—sarcoma	4.27e-07	0.0018	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—sarcoma	4.26e-07	0.0018	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—sarcoma	4.21e-07	0.00177	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—IL2—sarcoma	4.17e-07	0.00176	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—IL2—sarcoma	4.08e-07	0.00172	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—CCND1—sarcoma	4.07e-07	0.00171	CbGpPWpGaD
Etoposide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—sarcoma	4e-07	0.00169	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—KRAS—sarcoma	3.96e-07	0.00167	CbGpPWpGaD
Etoposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	3.92e-07	0.00165	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—MYC—sarcoma	3.92e-07	0.00165	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	3.84e-07	0.00162	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—sarcoma	3.84e-07	0.00162	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—sarcoma	3.84e-07	0.00162	CbGpPWpGaD
Etoposide—TOP2A—Circadian rythm related genes—TP53—sarcoma	3.77e-07	0.00159	CbGpPWpGaD
Etoposide—ABCC1—Disease—TLE1—sarcoma	3.72e-07	0.00157	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—sarcoma	3.69e-07	0.00155	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—KRAS—sarcoma	3.62e-07	0.00153	CbGpPWpGaD
Etoposide—ABCB1—Allograft Rejection—VEGFA—sarcoma	3.47e-07	0.00146	CbGpPWpGaD
Etoposide—PTGS2—C-MYB transcription factor network—HRAS—sarcoma	3.36e-07	0.00142	CbGpPWpGaD
Etoposide—ABCC1—Disease—NPM1—sarcoma	3.36e-07	0.00141	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—MYC—sarcoma	3.26e-07	0.00137	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—EGFR—sarcoma	3.19e-07	0.00134	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	3.18e-07	0.00134	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—ENO2—sarcoma	3.11e-07	0.00131	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—HBA1—sarcoma	3.09e-07	0.0013	CbGpPWpGaD
Etoposide—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—sarcoma	3.08e-07	0.0013	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MDM2—sarcoma	2.96e-07	0.00125	CbGpPWpGaD
Etoposide—ABCC1—Disease—ENO2—sarcoma	2.91e-07	0.00123	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—CCND1—sarcoma	2.88e-07	0.00121	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	2.77e-07	0.00117	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	2.76e-07	0.00116	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	2.74e-07	0.00115	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—sarcoma	2.72e-07	0.00115	CbGpPWpGaD
Etoposide—PTGS2—Spinal Cord Injury—TP53—sarcoma	2.68e-07	0.00113	CbGpPWpGaD
Etoposide—ABCC3—Metabolism—PLCG1—sarcoma	2.64e-07	0.00111	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—CCND1—sarcoma	2.58e-07	0.00109	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—ENO2—sarcoma	2.53e-07	0.00106	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—HBA1—sarcoma	2.51e-07	0.00106	CbGpPWpGaD
Etoposide—PTGS2—Disease—TLE1—sarcoma	2.5e-07	0.00105	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	2.48e-07	0.00104	CbGpPWpGaD
Etoposide—ABCC1—Disease—PLCG1—sarcoma	2.47e-07	0.00104	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—ENO2—sarcoma	2.44e-07	0.00103	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—HBA1—sarcoma	2.42e-07	0.00102	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	2.41e-07	0.00102	CbGpPWpGaD
Etoposide—ABCC1—Disease—CXCR4—sarcoma	2.37e-07	0.000999	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle, Mitotic—MYC—sarcoma	2.31e-07	0.000974	CbGpPWpGaD
Etoposide—PTGS2—Disease—NPM1—sarcoma	2.25e-07	0.000949	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—sarcoma	2.25e-07	0.000949	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	2.22e-07	0.000935	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	2.17e-07	0.000914	CbGpPWpGaD
Etoposide—UGT1A1—Metabolism—PLCG1—sarcoma	2.14e-07	0.000903	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—ENO2—sarcoma	2.14e-07	0.000903	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—HBA1—sarcoma	2.13e-07	0.000897	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—MYC—sarcoma	2.07e-07	0.000871	CbGpPWpGaD
Etoposide—ABCC1—Metabolism—PLCG1—sarcoma	2.07e-07	0.000871	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—ENO2—sarcoma	2.06e-07	0.000868	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	2.05e-07	0.000864	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—HBA1—sarcoma	2.05e-07	0.000862	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—sarcoma	1.96e-07	0.000826	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—sarcoma	1.96e-07	0.000825	CbGpPWpGaD
Etoposide—PTGS2—Disease—ENO2—sarcoma	1.95e-07	0.000822	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—CTNNB1—sarcoma	1.94e-07	0.000818	CbGpPWpGaD
Etoposide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.82e-07	0.000768	CbGpPWpGaD
Etoposide—ABCG2—Metabolism—PLCG1—sarcoma	1.82e-07	0.000766	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—sarcoma	1.76e-07	0.00074	CbGpPWpGaD
Etoposide—ABCC1—Disease—FOXO1—sarcoma	1.75e-07	0.000738	CbGpPWpGaD
Etoposide—ABCC1—Disease—PDGFRB—sarcoma	1.75e-07	0.000737	CbGpPWpGaD
Etoposide—PTGS1—Metabolism—PLCG1—sarcoma	1.75e-07	0.000736	CbGpPWpGaD
Etoposide—ABCC1—Disease—PDGFRA—sarcoma	1.72e-07	0.000725	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—sarcoma	1.71e-07	0.00072	CbGpPWpGaD
Etoposide—TOP2A—Cell Cycle—TP53—sarcoma	1.7e-07	0.000715	CbGpPWpGaD
Etoposide—PTGS2—Disease—PLCG1—sarcoma	1.66e-07	0.000698	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—ENO2—sarcoma	1.64e-07	0.000689	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—HBA1—sarcoma	1.62e-07	0.000684	CbGpPWpGaD
Etoposide—PTGS2—Disease—CXCR4—sarcoma	1.59e-07	0.00067	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—sarcoma	1.57e-07	0.000663	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—ENO2—sarcoma	1.54e-07	0.000648	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—sarcoma	1.54e-07	0.000648	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—ENO2—sarcoma	1.54e-07	0.000647	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—HBA1—sarcoma	1.53e-07	0.000644	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—HBA1—sarcoma	1.53e-07	0.000643	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—sarcoma	1.45e-07	0.000612	CbGpPWpGaD
Etoposide—PTGS2—Metabolism—PLCG1—sarcoma	1.39e-07	0.000584	CbGpPWpGaD
Etoposide—ABCC1—Disease—KIT—sarcoma	1.33e-07	0.000562	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—ENO2—sarcoma	1.33e-07	0.00056	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—HBA1—sarcoma	1.32e-07	0.000557	CbGpPWpGaD
Etoposide—CYP2E1—Metabolism—PLCG1—sarcoma	1.31e-07	0.00055	CbGpPWpGaD
Etoposide—CYP3A5—Metabolism—PLCG1—sarcoma	1.3e-07	0.000549	CbGpPWpGaD
Etoposide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—sarcoma	1.29e-07	0.000544	CbGpPWpGaD
Etoposide—ABCC1—Disease—CREB1—sarcoma	1.27e-07	0.000535	CbGpPWpGaD
Etoposide—PTGS2—Disease—FOXO1—sarcoma	1.18e-07	0.000495	CbGpPWpGaD
Etoposide—PTGS2—Disease—PDGFRB—sarcoma	1.17e-07	0.000494	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—ENO2—sarcoma	1.16e-07	0.000488	CbGpPWpGaD
Etoposide—PTGS2—Disease—PDGFRA—sarcoma	1.16e-07	0.000487	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—HBA1—sarcoma	1.15e-07	0.000485	CbGpPWpGaD
Etoposide—CYP2C8—Metabolism—PLCG1—sarcoma	1.13e-07	0.000476	CbGpPWpGaD
Etoposide—ABCC1—Disease—MDM2—sarcoma	1.05e-07	0.000443	CbGpPWpGaD
Etoposide—ABCB1—Metabolism—PLCG1—sarcoma	9.84e-08	0.000414	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—ENO2—sarcoma	9.25e-08	0.00039	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—HBA1—sarcoma	9.2e-08	0.000387	CbGpPWpGaD
Etoposide—ABCC1—Disease—CTNNB1—sarcoma	9.07e-08	0.000382	CbGpPWpGaD
Etoposide—PTGS2—Disease—KIT—sarcoma	8.96e-08	0.000377	CbGpPWpGaD
Etoposide—PTGS2—Disease—CREB1—sarcoma	8.53e-08	0.000359	CbGpPWpGaD
Etoposide—ABCC1—Disease—SRC—sarcoma	8.2e-08	0.000345	CbGpPWpGaD
Etoposide—ABCC1—Disease—NRAS—sarcoma	7.88e-08	0.000332	CbGpPWpGaD
Etoposide—CYP1A2—Metabolism—PLCG1—sarcoma	7.85e-08	0.000331	CbGpPWpGaD
Etoposide—ABCC1—Disease—MYC—sarcoma	7.34e-08	0.000309	CbGpPWpGaD
Etoposide—ABCC1—Disease—EGFR—sarcoma	7.18e-08	0.000303	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—ENO2—sarcoma	7.14e-08	0.000301	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—HBA1—sarcoma	7.1e-08	0.000299	CbGpPWpGaD
Etoposide—PTGS2—Disease—MDM2—sarcoma	7.05e-08	0.000297	CbGpPWpGaD
Etoposide—ABCC1—Disease—KRAS—sarcoma	6.79e-08	0.000286	CbGpPWpGaD
Etoposide—PTGS2—Disease—CTNNB1—sarcoma	6.08e-08	0.000256	CbGpPWpGaD
Etoposide—CYP3A4—Metabolism—PLCG1—sarcoma	6.06e-08	0.000255	CbGpPWpGaD
Etoposide—ABCC1—Disease—HRAS—sarcoma	5.77e-08	0.000243	CbGpPWpGaD
Etoposide—PTGS2—Disease—SRC—sarcoma	5.5e-08	0.000232	CbGpPWpGaD
Etoposide—PTGS2—Disease—NRAS—sarcoma	5.29e-08	0.000223	CbGpPWpGaD
Etoposide—PTGS2—Disease—MYC—sarcoma	4.93e-08	0.000208	CbGpPWpGaD
Etoposide—PTGS2—Disease—EGFR—sarcoma	4.82e-08	0.000203	CbGpPWpGaD
Etoposide—PTGS2—Disease—KRAS—sarcoma	4.55e-08	0.000192	CbGpPWpGaD
Etoposide—PTGS2—Disease—HRAS—sarcoma	3.87e-08	0.000163	CbGpPWpGaD
